Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today highlighted data presented at the American Association ...
A diagram of the DRT3 system, showing Drt3a in yellow and Drt3b in blue. (Hyunbin Lee) Scientists have just discovered an ...
A newly proposed model suggests cancer cells may resist treatment not just through genetic mutations, but by dynamically ...
A clinical trial to reverse age-related vision conditions using stem cell treatment could finally deliver on the promise of a ...
SEED Therapeutics, Inc. (“SEED”), a clinical-stage biotechnology company pioneering rationally designed molecular glue ...
Following Flagship's origination of generative protein and mRNA platforms, Serif is pioneering Modified DNA medicines to program the foundational information layer of biology Serif to present data at ...
A new nanomedicine strategy enhances irinotecan delivery in pancreatic tumors, reduces resistance, and boosts antitumor ...
A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...
Endogenous Retroviruses (ERVs), relics from ancient viral infections, form a significant part of vertebrate genomes, including humans, where they constitute ...
From cooking at too high temperatures to consuming too little fat, what and how we eat can have a big impact on the way we age. Here’s what you might be doing wrong – and how to fix it ...